" class="no-js "lang="en-US"> Alzheimer's disease Archives - Medtech Alert
Thursday, February 09, 2023

Sort by:

Date

Top Post

CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer's disease

BioArctic AB‘s partner Eisai have announced that the European Medicines Agency (EMA) has accepted a […]

Eisai Submits Marketing Application for lecanemab for Alzheimer's

BioArctic AB’s partner Eisai announced today that Eisai has submitted a marketing authorization application for […]

  1. ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
  2. Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more
  3. Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform Read more
  4. FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate Read more
  5. $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders Read more